Evidence-biased Antidepressant Prescription: Overmedicalisation, Flawed Research, and Conflicts of Interest - Image 1

£91.49

MACMILLAN Evidence-biased Antidepressant Prescription: Overmedicalisation, Flawed Research, and Conflicts of Interest

Name: Evidence-biased Antidepressant Prescription: Overmedicalisation, Flawed Research, and Conflicts of Interest
Brand: MACMILLAN
Price: 91.49 GBP
Availability: InStock

Public Health & Preventive Medicine

It has never been this cheap. We have no record of a lower price.

£91 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 43 days · 43 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 43 days • 1 price levels

Days at Price

Price Analysis

Most common price: £91 (43 days, 100.0%)

Price range: £91 - £91

Price levels: 1 different prices over 43 days

Description

This book addresses the over-prescribing of antidepressants in people with mostly mild and subthreshold depression. It outlines the steep increase in antidepressant prescription and critically examines the current scientific evidence on the efficacy and safety of antidepressants in depression. The book is not only concerned with the conflicting views as to whether antidepressants are useful or ineffective in various forms of depression, but also aims at detailing how flaws in the conduct and reporting of antidepressant trials have led to an overestimation of benefits and underestimation of harms. The transformation of the diagnostic concept of depression from a rare but serious disorder to an over-inclusive, highly prevalent but predominantly mild and self-limiting disorder is central to the books argument. It maintains that biological reductionism in psychiatry and pharmaceutical marketing reframed depression as a brain disorder, corroboratingthe overemphasis on drug treatment in both research and practice. Finally, the author goes on to explore how pharmaceutical companies have distorted the scientific literature on the efficacy and safety of antidepressants and how patient advocacy groups, leading academics, and medical organisations with pervasive financial ties to the industry helped to promote systematically biased benefit-harm evaluations, affecting public attitudes towards antidepressants as well as medical education, training, and practice.

Product Specifications

Brand: MACMILLAN
Format: paperback
ASIN: 3030825892
Category: Books > Subjects > Science, Nature & Maths > Medicine > Medical Sciences A-Z > Public Health & Preventive Medicine
Domain: Amazon UK
Release Date: 11 December 2022
Listed Since: 13 November 2022

Barcode

No barcode data available

MACMILLAN Evidence-biased Antidepressant Prescription: Overmedicalisation, Flawed Research, and Conflicts of Interest

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)

Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)

Antidepressants (Milestones in Drug Therapy)

Antidepressants: Types, Efficiency & Possible Side Effects (Depression-Causes, Diagnosis, and Treatment)

The Myth of Depression as Disease: Limitations and Alternatives to Drug Treatment (Contemporary Psychology)

Differenzierte Therapie mit trizyklischen Antidepressiva

Antidepressants: New Pharmacological Strategies (Contemporary Neuroscience)

Antidepressants: New Pharmacological Strategies (Contemporary Neuroscience)

Prescriber's Guide: Antidepressants: Stahl's Essential Psychopharmacology

Neuro-Psychopharmaka Ein Therapie-Handbuch: Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer

Pharmacotherapy For Depression And Treatment-Resistant Depression

Pharmacotherapy of Depression

Melatonin, Neuroprotective Agents and Antidepressant Therapy

The Pharmacogenetics of Antidepressant Response: Moving towards Individualized Therapy - Improving Patient Outcomes through Optimization of Treatment Based on Genetic Makeup

Antidepressants Therapy & Risk of Suicide Among Patients with Major Depressive Disorders (Psychiatry - Theory, Applications and Treatments)

Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression (Disease and Desire)

Depression as a Systemic Illness

Treatment-Resistant Mood Disorders

Effectiveness of Second-Generation Antidepressants in Adult Depression Treatment (Public Health in the 21st Century Series) (Public Health in the 21st ... Causes, Diagnosis and Treatment)

Prevention and Early Treatment of Depression Through the Life Course (Depression and Personality)

EFFETS DES ANTIDÉPRESSEURS SUR DES MODÈLES MURINS: Etude de la variabilité et de la taille de l'effet des antidépresseurs sur des modèles comportementaux et neurobiologiques (Omn.Univ.Europ.)

All about Depression

Complete Depression Treatment: 183 (PracticePlanners)

Rapid Acting Antidepressants: Volume 89 (Advances in Pharmacology, Volume 89)